Isabel
Iriepa Canalda
Profesor/a Titular Universidad
Instituto de Química Orgánica General
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Química Orgánica General (45)
2024
-
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors
ACS Chemical Neuroscience, Vol. 15, Núm. 18, pp. 3363-3383
2023
-
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
International Journal of Molecular Sciences, Vol. 24, Núm. 11
-
Straightforward Synthesis of Bis[(trifluoromethyl)sulfonyl]ethylated Isocoumarins from 2-Ethynylbenzoates
Journal of Organic Chemistry, Vol. 88, Núm. 11, pp. 7373-7380
2022
-
N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
Molecules, Vol. 27, Núm. 21
-
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
ACS Pharmacology and Translational Science, Vol. 5, Núm. 11, pp. 1097-1108
2021
-
Privileged quinolylnitrones for the combined therapy of ischemic stroke and alzheimer’s disease
Pharmaceuticals, Vol. 14, Núm. 9
-
Studies on the affinity of 6-[(: N -(cyclo)aminoalkyl)oxy]-4 H -chromen-4-ones for sigma 1/2 receptors
RSC Medicinal Chemistry, Vol. 12, Núm. 6, pp. 1000-1004
-
Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
ChemistrySelect, Vol. 6, Núm. 37, pp. 9975-9980
-
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments
Chemical Record, Vol. 21, Núm. 1, pp. 162-174
2020
-
Acetylcholinesterase inhibition of diversely functionalized quinolinones for alzheimer’s disease therapy
International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-20
-
Automated Synthesis of New Quinoxalinetacrines
ChemistrySelect, Vol. 5, Núm. 21, pp. 6491-6493
-
Synthesis of hantzsch adducts as cholinesterases and calcium flux inhibitors, antioxidants and neuroprotectives
International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-19
-
Triazolopyridopyrimidine: A new scaffold for dual-target small molecules for Alzheimer's disease therapy
Molecules, Vol. 25, Núm. 14
2019
-
Chromenones as Multineurotargeting Inhibitors of Human Enzymes
ACS Omega, Vol. 4, Núm. 26, pp. 22161-22168
-
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489
-
Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy
Bioorganic Chemistry, Vol. 91
-
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422
-
Novel Quinolylnitrones Combining Neuroprotective and Antioxidant Properties
ACS Chemical Neuroscience, Vol. 10, Núm. 6, pp. 2703-2706
-
Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy
Molecules, Vol. 24, Núm. 8
-
Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 163-170